Contents of this Pandemic Journal produced in partnership with Groupe VYV and led by Dr Jean-François Lemoine: How effective are vaccines on new variants? Are these a real threat, more contagious, more pathogenic? And the point on the debate concerning the spacing between two doses which opposes the Academy of Medicine and the health authorities in charge of the vaccination campaign.
Contents of this Pandemic Journal of April 20, 2021, led by Dr Jean-François Lemoine:
- Professor Jean-Paul Stahl returns to the differences in efficacy between messenger RNA vaccines and viral vector vaccines, emphasizing that the former retain high efficacy against the South African and Brazilian variants.
- Professor Yves Gaudin, virologist, takes stock of the dangerousness of the new South African and Brazilian variants… and specifies that the most probable evolution of the coronavirus will be a succession of mutations which should make it less contagious and less pathogenic.
- Professor Francois Carré evokes the nascent controversy over the vaccination demanded by some top athletes on the eve of the Olympic Games.
.
